Hutchmed (china) Limited announced that Dr. Hu Chaohong will serve as the company's independent non-executive director and a member of the technical committee starting from November 21, 2024. Dr. Hu has over 20 years of rich experience in the biomedical field, specializing in therapeutic antibodies, antibody-drug conjugates, and vaccine development. She has held senior positions in several well-known biotechnology companies and successfully founded and led Shanghai Meiake Biotechnology Co., Ltd. Dr. Elde, chairman of Hutchmed, warmly welcomed Dr. Hu's joining and looks forward to her bringing new perspectives and constructive insights to the board of directors. Dr. Hu's appointment will terminate at the end of the next shareholders' annual general meeting unless terminated early or not re-elected. She will receive an annual salary of $76,000 and an additional $8,000 as compensation for being a member of the technical committee.

Hutchmed (china) Limited announced that Dr. Hu Chaohong will serve as the company's independent non-executive director and a member of the technical committee starting from November 21, 2024. Dr. Hu has over 20 years of rich experience in the biomedical field, specializing in therapeutic antibodies, antibody-drug conjugates, and vaccine development. She has held senior positions in several well-known biotechnology companies and successfully founded and led Shanghai Meiake Biotechnology Co., Ltd. Dr. Elde, chairman of Hutchmed, warmly welcomed Dr. Hu's joining and looks forward to her bringing new perspectives and constructive insights to the board of directors. Dr. Hu's appointment will terminate at the end of the next shareholders' annual general meeting unless terminated early or not re-elected. She will receive an annual salary of $76,000 and an additional $8,000 as compensation for being a member of the technical committee.